ATP6AP2 and glioblastoma: Although this study did not explore the targeting of RAS components, inhibition of RAS receptors such as AGTR1, AGTR2, and ATP6AP2 have been demonstrated to reduce glioblastoma cell growth, proliferation, and/or angiogenesis [19,21,22,23,53,54].